The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. (Q33755648)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

angiogenesis inhibitor

1 reference

based on heuristic

inferred from title

object named as

Ricardo Gomez

14

0 references

Tinnakorn Chaiworapongsa

10

object named as

Tinnakorn Chaiworapongsa

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Francesca Gotsch

7

object named as

Francesca Gotsch

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Juan Pedro Kusanovic

6

object named as

Juan Pedro Kusanovic

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shali Mazaki-Tovi

12

object named as

Shali Mazaki-Tovi

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1

object named as

Offer Erez

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

object named as

Pooja Mittal

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

object named as

Roberto Romero

2

1 reference

ORCID Public Data File 2021

3

object named as

Jimmy Espinoza

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

object named as

David Todem

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

object named as

Jyh Kae Nien

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Nandor Gabor Than

13

object named as

Nandor Gabor Than

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Wenjiang Fu

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Samuel Edwin

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sonia S Hassan

15

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

publication date

1 May 2008

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Journal of Maternal-Fetal and Neonatal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

279-287

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Soluble endoglin contributes to the pathogenesis of preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

The risk of preeclampsia rises with increasing prepregnancy body mass index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

A longitudinal study of biochemical variables in women at risk of preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Vascular endothelial growth factor is increased in patients with preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

A multivariate analysis of risk factors for preeclampsia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

21 June 2018

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Urinary Placental Growth Factor and Risk of Preeclampsia

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Maternal body mass index and the risk of preeclampsia: a systematic overview

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

A national birth weight distribution curve according to gestational age in Chile from 1993 to 2000

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2846114

30 October 2018

Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

1 reference

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

2 references

https://api.crossref.org/works/10.1080%2F14767050802034545

21 January 2018

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-pregnancy body mass index and pregnancy outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors and clinical manifestations of pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma placenta growth factor levels in midtrimester pregnancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Underappreciated risks of the elderly multipara

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localisation of placenta growth factor (PIGF) in human term placenta

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of pre-eclampsia in women at high risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endoglin (CD 105) expression in human lymphoid organs and placenta

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preeclampsia is associated with reduced serum levels of placenta growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of an 'anti-angiogenic state' in complications of pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age

1 reference

https://pubmed.ncbi.nlm.nih.gov/18446652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1080/14767050802034545

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33755648&oldid=1961691760"